- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01802801
Intra- and Interobserver Agreement in the Assessment of Human Embryos
February 28, 2013 updated by: Thomas D'Hooghe, University Hospital, Gasthuisberg
Intra-and Inter-observer Agreement in the Morphological Assessment of Human Embryos
The purpose of this study is to determine the intra- and interobserver agreement.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium
- University Hospital Leuven, Catholic University Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 3 days (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
embryos of IVF/ICSI patients
Description
Inclusion Criteria:
- fertilized embryos
Exclusion Criteria:
- unfertilized embryos
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
|
intra- and inter-observator analysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
Evaluation of the intra- and inter-observer variability in the assessement of human embryos
|
Variation in observer assessment of embryo characteristics on day 1, 2 and 3 of embryo development.
Assessment of these characteristics is standard procedure.
Safety and tolerability or efficacy issues are not relevant for this outcome.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
July 1, 2009
Study Completion (Actual)
August 1, 2009
Study Registration Dates
First Submitted
March 25, 2010
First Submitted That Met QC Criteria
February 28, 2013
First Posted (Estimate)
March 1, 2013
Study Record Updates
Last Update Posted (Estimate)
March 1, 2013
Last Update Submitted That Met QC Criteria
February 28, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- GP12122007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.